Cambridge Molecular is a computational chemistry software company devoted to DNA-encoded libraries and other next-generation small molecular screening technologies. We enable our partners' discovery efforts with cutting-edge algorithms packaged into user-friendly software applications.
We are the developer of the Palladium DEL Follow-Up Suite, a downloadable software application that enables fast, simple, and powerful analyses of DEL data. It can also carry out rapid 2D and 3D DEL-based virtual screens into catalogues of readily accessible compounds.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 1010 Cambourne Business Centre, Cambridge,england Cb23 6dp,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sublime.bio
- HQ
- Cambridge, England
Cambridge Molecular Questions
Cambridge Molecular's website is sublime.bio
Cambridge Molecular's LinkedIn profile is https://uk.linkedin.com/company/cambridgemolecular
Cambridge Molecular has
2 employees.
View email and phone details for 2
employees at Cambridge Molecular.
Cambridge Molecular's industry is
Biotechnology Research
Cambridge Molecular's top competitors are
Planetari,
Biothea Pharma Inc.,
Spaid,
Spaid,
Cambridge Life Sciences,
Tmt Investments Plc,
Cambridge Biosolutions,
Scicaliber,
Openbiosim Community Interest Company,
Cambridge Reagents.
Cambridge Molecular's categories are Biotechnology Research
Cambridge Molecular's founding year is 2019
